• No results found

18 results with keyword: 'effects natalizumab treatment cerebrospinal proteome multiple sclerosis patients'

Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients

This validation procedure showed that the peptides of these proteins were significantly lower in concentration in CSF of MScl patients after treatment with natalizumab in a

Protected

N/A

20
0
0
2021
Minimizing the expected weighted number of tardy jobs with non-identically distributed processing times and due dates

Theorem 3.1 also implies that when the due dates are independent, identically distributed random variables and all the weights are the same, an optimal sequence is obtained if

Protected

N/A

7
0
0
2022
MULTI CROSS PROTOCOL WITH HYBRID TOPOGRAPHY CONTROL FOR MANETS

The solution of the inverse heat conduction problem by infrared images obtained with the UAV allowed detecting objects by similar thermal parameters; image segmentation of

Protected

N/A

6
0
0
2020
This insurance is a Contract of Indemnity between the Insurer and You, the insured.

This policy covers You for all sums You become legally liable to pay for death of or injury to any person and damage to any other person’s property as a

Protected

N/A

19
0
0
2021
Multi-scale Assessment of Northern Bobwhite and White-tailed Deer Habitat Selection in Longleaf Pine Woodlands.

Bobwhite selected areas with 2–7 m 2 /ha hardwoods in uplands, potentially because of the availability of mast, but avoided uplands when either pine or hardwood basal area exceeded

Protected

N/A

87
0
0
2020
transplantation with neurological disability and other clinical outcomes in patients with MS.

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients

Protected

N/A

10
0
0
2021
USGS OFFICE OF ORGANIZATIONAL AND EMPLOYEE DEVELOPMENT (OED) LEARNING SUPPORT SERVICE

DOI Agencies and offices include: Bureau of Land Management (BLM), Bureau of Ocean Energy Management and Bureau of Safety and Environmental Enforcement (BOEM-BSEE), Bureau of

Protected

N/A

5
0
0
2021
Optimizing Therapy in Progressive MS: Treatment Options

– Natalizumab Treatment of Progressive Multiple Sclerosis (NAPMS): phase II trial to study safety and efficacy of natalizumab in treatment of primary and secondary

Protected

N/A

62
0
0
2021
How Dispute Resolution System Design Matters: An Organizational Analysis of Dispute Resolution Structures and Consumer Lemon Laws*

Specifically, I compare an instance where powerful state consumer protection laws are resolved in private dispute resolution forums funded by automobile manufacturers but operated

Protected

N/A

34
0
0
2022
Family of Imaging Systems

Whether you are looking to improve your Western blot data by simply moving to digital chemiluminescent detection or by transitioning to quantitative Western blot technology using

Protected

N/A

22
0
0
2021
Natalizumab in the treatment of multiple sclerosis

Twelve percent of the patients receiving natalizumab and interferon β -1a developed antibodies at some time during the trial, whereas 6% displayed persistent

Protected

N/A

10
0
0
2020
Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients. Cochrane Database

Protected

N/A

12
0
0
2021
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing Remitting Multiple Sclerosis

CONCLUSIONS: In patients with relapsing-remitting multiple sclerosis starting natalizumab treatment, the extent and severity of white matter damage were reduced significantly in the

Protected

N/A

8
0
0
2020
Establishing the resilient response of organisations to disruptions: an exploration of organisational resilience

The standard helps organisations establish the fundamental aspects of Business Continuity Management System ( Article-EON-003 ). Rather than follow a prescriptive

Protected

N/A

430
0
0
2021
Limited progress in closing the mortality gap for Aboriginal and Torres Strait Islander Australians of the Northern Territory

If Aboriginal and Torres Strait Islander childhood mortality (across ages 0–14 years) were to fall to the same rates experienced by the Australian population as a whole in

Protected

N/A

7
0
0
2021
Natalizumab in the treatment of pediatric multiple sclerosis

Relapse 12 (M32) presented with alternating truncal as well as cerebellar symptomatology (EDSS=3.5) and with corresponding progression of the number of active cerebral and

Protected

N/A

11
0
0
2021
Using waste heat. with gas-fired steam humidifiers Condair GS. Humidification and evaporative cooling

exhaust gas heat is used and regenerated through heat recovery in the HVaC unit, and the quality of exhaust air does not decrease in the process.. the energy in the exhaust gas

Protected

N/A

8
0
0
2021
Consultation Paper CP27/14. CRD IV: Liquidity

Internal Liquidity Adequacy Assessment Process 2.4 The ILAA rules include requirements on firms to identify, measure, manage and monitor liquidity and funding risk across

Protected

N/A

99
0
0
2021

Upload more documents and download any material studies right away!